Purinergic regulation of pulmonary vascular tone.

Weibel ER (2017) Lung morphometry: the link between structure and function. Cell Tissue Res 367(3):413–426. https://doi.org/10.1007/s00441-016-2541-4

doi: 10.1007/s00441-016-2541-4 pubmed: 27981379

Hsia CCW, Hyde DM, Weibel ER (2016). Lung structure and the intrinsic challenges of gas exchange. Comprehensive physiology. Hoboken, NJ, USA: John Wiley & Sons, Inc 827–95. https://doi.org/10.1002/cphy.c150028

Clark A, Tawhai M (2019). Pulmonary vascular dynamics. In: Comprehensive physiology Wiley 1081–100. https://doi.org/10.1002/cphy.c180033

Vaillancourt M, Chia P, Sarji S, Nguyen J, Hoftman N, Ruffenach G et al (2017) Autonomic nervous system involvement in pulmonary arterial hypertension. Respir Res 18:201. https://doi.org/10.1186/s12931-017-0679-6

doi: 10.1186/s12931-017-0679-6 pubmed: 29202826 pmcid: 5715548

Sylvester JT, Shimoda LA, Aaronson PI, Ward JPT (2012) Hypoxic pulmonary vasoconstriction. Physiol Rev 92(1):367–520

pubmed: 22298659 doi: 10.1152/physrev.00041.2010

Goldenberg NM, Kuebler WM (2015). Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Comprehensive physiology. Hoboken, NJ, USA: John Wiley & Sons, Inc 531–59. https://doi.org/10.1002/cphy.c140024

Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207–228. https://doi.org/10.1161/CIRCRESAHA.116.309726

doi: 10.1161/CIRCRESAHA.116.309726 pubmed: 28057794

Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - An update. Pharmacol Rev 63(1):1–34

pubmed: 21303899 pmcid: 3061413 doi: 10.1124/pr.110.003285

North RA (2002) Molecular physiology of P2X receptors. Physiol Rev Am Physiol Soc 82:1013–1067

von Kügelgen I (2019) Pharmacology of P2Y receptors. Brain Res Bull 151:12–24. https://doi.org/10.1016/j.brainresbull.2019.03.010

doi: 10.1016/j.brainresbull.2019.03.010

O’Connor SE, Dainty IA, Leff P (1991) Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 12(C):137–41

pubmed: 2063479 doi: 10.1016/0165-6147(91)90530-6

Burnstock G, Ralevic V (2013) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66(1):102–192

pubmed: 24335194 doi: 10.1124/pr.113.008029

Zimmermann H (2021) Ectonucleoside triphosphate diphosphohydrolases and ecto-5′-nucleotidase in purinergic signaling: how the field developed and where we are now. Purinergic Signal 17(1):117–125

pubmed: 33336318 doi: 10.1007/s11302-020-09755-6

Goueli SA, Hsiao K (2019) Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39. PLoS ONE 14(10):1–19

doi: 10.1371/journal.pone.0220094

Allard B, Longhi MS, Robson SC, Stagg J (2017) The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev 276:121–144

pubmed: 28258700 pmcid: 5338647 doi: 10.1111/imr.12528

Robson SC, Sévigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2(2):409–430. https://doi.org/10.1007/s11302-006-9003-5

doi: 10.1007/s11302-006-9003-5 pubmed: 18404480 pmcid: 2254478

Eckle T, Füllbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J et al (2007) Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178(12):8127–8137

pubmed: 17548651 doi: 10.4049/jimmunol.178.12.8127

Burch LH, Picher M (2006) E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signalling 2:399–408

pubmed: 18404479 pmcid: 2096640 doi: 10.1007/s11302-006-9001-7

Stevens T, Phan S, Frid MG, Alvarez D, Herzog E, Stenmark KR (2008) Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc Am Thorac Soc 5(7):783–791. https://doi.org/10.1513/pats.200803-027HR

Chootip K, Ness KF, Wang Y, Gurney AM, Kennedy C (2002) Regional variation in P2 receptor expression in the rat pulmonary arterial circulation. Br J Pharmacol 137(5):637–646

pubmed: 12381677 pmcid: 1573537 doi: 10.1038/sj.bjp.0704915

Lewis CJ, Evans RJ (2001) P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 38(4):332–340

pubmed: 11455204 doi: 10.1159/000051064

Huang C, Hu J, Subedi KP, Lin AHY, Paudel O, Ran P et al (2015) Extracellular adenosine diphosphate ribose mobilizes intracellular Ca 2+ via purinergic-dependent Ca 2+ pathways in rat pulmonary artery smooth muscle cells. Cell Physiol Biochem 37(5):2043–2059

pubmed: 26584302 doi: 10.1159/000438564

Mitchell C, Syed NH, Tengah A, Gurney AM, Kennedy C (2012) Identification of contractile P2Y

pubmed: 22991416 doi: 10.1124/jpet.112.198051

Syed N-H, Tengah A, Paul A, Kennedy C (2010) Characterisation of P2X receptors expressed in rat pulmonary arteries. Eur J Pharmacol 649(1–3):342–348

pubmed: 20868665 doi: 10.1016/j.ejphar.2010.09.041

Hartley SA, Kato K, Salter KJ, Kozlowski RZ (1998) Functional evidence for a novel suramin-insensitive pyrimidine receptor in rat small pulmonary arteries. Circ Res 83(9):940–946

pubmed: 9797343 doi: 10.1161/01.RES.83.9.940

Rubino A, Ziabary L, Burnstock G (2019) Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries. Eur J Pharmacol 370(2):139–143

doi: 10.1016/S0014-2999(99)00150-8

Liu SF, McCormack DG, Evans TW, Barnes PJ (1989) Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels. J Pharmacol Exp Ther 251(3):1204–1210

pubmed: 2600811

Henriquez M, Fonseca M, Perez-Zoghbi JF (2018) Purinergic receptor stimulation induces calcium oscillations and smooth muscle contraction in small pulmonary veins. J Physiol 596(13):2491–2506

pubmed: 29790164 pmcid: 6023829 doi: 10.1113/JP274731

Kiefmann R, Islam MN, Lindert J, Parthasarathi K, Bhattacharya J (2009) Paracrine purinergic signaling determines lung endothelial nitric oxide production. Am J Physiol Cell Mol Physiol 296(6):L901–L910. https://doi.org/10.1152/ajplung.90549.2008

doi: 10.1152/ajplung.90549.2008

Baek EB, Yoo HY, Park SJ, Kim HS, Kim SD, Earm YE et al (2008) Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure. Pflügers Arch - Eur J Physiol 457(2):281–291. https://doi.org/10.1007/s00424-008-0536-z

doi: 10.1007/s00424-008-0536-z

Hasséssian H, Bodin P, Burnstock G (1993) Blockade by glibenclamide of the flow-evoked endothelial release of ATP that contributes to vasodilatation in the pulmonary vascular bed of the rat. Br J Pharmacol 109(2):466–472

pubmed: 8358546 doi: 10.1111/j.1476-5381.1993.tb13592.x

Sprague RS, Olearczyk JJ, Spence DM, Stephenson AH, Sprung RW, Lonigro AJ (2003) Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Circ Physiol 285(2):H693-700

doi: 10.1152/ajpheart.01026.2002

Mitchell C, Syed NIH, Gurney AM, Kennedy C (2012) A Ca 2+-dependent chloride current and Ca 2+ influx via Ca v1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction. Br J Pharmacol 166(4):1503–12

pubmed: 22320222 pmcid: 3417463 doi: 10.1111/j.1476-5381.2012.01892.x

Moerenhout M, Himpens B, Vereecke J (2001) Intercellular communication upon mechanical stimulation of CPAE-endothelial cells is mediated by nucleotides. Cell Calcium 29(2):125–136

pubmed: 11162850 doi: 10.1054/ceca.2000.0165

Robaye B, Boeynaems JM, Communi D (1997) Slow desensitization of the human P2Y

pubmed: 9226417 doi: 10.1016/S0014-2999(97)89184-4

Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276(15):11939–48

pubmed: 11114308 doi: 10.1074/jbc.M009909200

Flores RV, Hernández-Pérez MG, Aquino E, Garrad RC, Weisman GA, Gonzalez FA (2005) Agonist-induced phosphorylation and desensitization of the P2Y

pubmed: 16311903 pmcid: 1633720 doi: 10.1007/s11010-005-8050-5

Jarvis MF, Khakh BS (2009) ATP-gated P2X cation-channels. Neuropharmacology 56:208–215

pubmed: 18657557 doi: 10.1016/j.neuropharm.2008.06.067

Koshimizu TA, Koshimizu M, Stojilkovic SS (1999) Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem 274(53):37651–37657

pubmed: 10608821 doi: 10.1074/jbc.274.53.37651

Burnstock G, Kennedy C (2011) P2X receptors in health and disease. Adv Pharmacol 61:333–72. https://doi.org/10.1016/B978-0-12-385526-8.00011-4

doi: 10.1016/B978-0-12-385526-8.00011-4 pubmed: 21586364

Hasséssian H, Burnstock G (1995) Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat. Br J Pharmacol 114(4):846–850

pubmed: 7773545 pmcid: 1510219 doi: 10.1111/j.1476-5381.1995.tb13281.x

Hakim TS, Ferrario L, Freedman JC, Carlin RE, Camporesi EM (1997) Segmental pulmonary vascular responses to ATP in rat lungs: role of nitric oxide. J Appl Physiol 82(3):852–858

pubmed: 9074974 doi: 10.1152/jappl.1997.82.3.852

Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N et al (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12(1):133–137

pubmed: 16327800 doi: 10.1038/nm1338

Yamamoto K, Sokabe T, Ohura N, Nakatsuka H, Kamiya A, Ando J (2003) Endogenously released ATP mediates shear stress-induced Ca2+ influx into pulmonary artery endothelial cells. Am J Physiol - Hear Circ Physiol 285(2 54-2):793–803

doi: 10.1152/ajpheart.01155.2002

Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM (2002) Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol - Cell Physiol 282(2 51-2):289–301

doi: 10.1152/ajpcell.01387.2000

Yamamoto K, Korenaga R, Kamiya A, Ando J (2000) Fluid shear stress activates Ca

doi: 10.1161/01.RES.87.5.385 pubmed: 10969036

Yamamoto K, Korenaga R, Kamiya A, Qi Z, Sokabe M, Ando J (2000) P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol - Hear Circ Physiol 279(1 48-1):285–92

doi: 10.1152/ajpheart.2000.279.1.H285

Mertens TCJ, Hanmandlu A, Tu L, Phan C, Collum SD, Chen NY et al (2018) Switching-off ADORA2B in vascular smooth muscle cells halts the development of pulmonary hypertension. Front Physiol 9:555

pubmed: 29910735 pmcid: 5992271 doi: 10.3389/fphys.2018.00555

Lustig KD, Erb L, Landis DM, Hicks-Taylor CS, Zhang X, Sportiello MG et al (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim Biophys Acta - Mol Cell Res 1134(1):61–72

doi: 10.1016/0167-4889(92)90028-A

Qasabian RA, Schyvens C, Owe-Young R, Killen JP, Macdonald PS, Conigrave AD et al (1997) Characterization of the P2 receptors in rabbit pulmonary artery. Br J Pharmacol 120(4):553–558

pubmed: 9051289 pmcid: 1564495 doi: 10.1038/sj.bjp.0700924

North RA (2016) P2X receptors. Philos Trans R Soc B Biol Sci 371(1700):20150427. https://doi.org/10.1098/rstb.2015.0427

doi: 10.1098/rstb.2015.0427

Von Kügelgen I, Hoffmann K (2016) Pharmacology and structure of P2Y receptors. Neuropharmacology 104:50–61

doi: 10.1016/j.neuropharm.2015.10.030

Guibert C, Pacaud P, Loirand G, Marthan R, Savineau JP (1996) Effect of extracellular ATP on cytosolic Ca2+ concentration in rat pulmonary artery myocytes. Am J Physiol 271(3 Pt 1):L450–L458

pubmed: 8843794

Chootip K, Gurney AM, Kennedy C (2005) Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery. Respir Res 6(1):124

pubmed: 16250909 pmcid: 1282591 doi: 10.1186/1465-9921-6-124

Hartley SA, Kozlowski RZ (1997) Electrophysiological consequences of purinergic receptor stimulation in isolated rat pulmonary arterial myocytes. Circ Res 80(2):170–178. https://doi.org/10.1161/01.res.80.2.170

doi: 10.1161/01.res.80.2.170 pubmed: 9012739

Zheng YM, Wang QS, Rathore R, Zhang WH, Mazurkiewicz JE, Sorrentino V et al (2005) Type-3 ryanodine receptors mediate hypoxia-, but not neurotransmitter- induced calcium release and contraction in pulmonary artery smooth muscle cells. J Gen Physiol 125(4):427–440

pubmed: 15795312 pmcid: 2217508 doi: 10.1085/jgp.200409232

Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341

pubmed: 16968944 doi: 10.1124/pr.58.3.3

Berg J, Yang H, Jan LY (2012) Ca2+-activated Cl-channels at a glance. J Cell Sci 125(6):1367–1371

pubmed: 22526416 pmcid: 3336373 doi: 10.1242/jcs.093260

Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signalling 4(1):1–20. https://doi.org/10.1007/s11302-007-9078-7

doi: 10.1007/s11302-007-9078-7 pubmed: 18368530

Eichinger MR, Walker BR (1994) Segmental heterogeneity of NO-mediated pulmonary vasodilation in rats. Am J Physiol 267(2 Pt 2):H494–H499

pubmed: 8067401

Liu SF, McCormack DG, Evans TW, Barnes PJ (1989) Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels. J Pharmacol Exp Ther 251(3):1204–1210

pubmed: 2600811

Liu SF, McCormack DG, Evans TW, Barnes PJ (1989) Evidence for two P2-purinoceptor subtypes in human small pulmonary arteries. Br J Pharmacol 98(3):1014–1020

pubmed: 2590768 pmcid: 1854747 doi: 10.1111/j.1476-5381.1989.tb14633.x

Greenberg B, Rhoden K, Barnes PJ (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol Circ Physiol 252(2):H434–H438

doi: 10.1152/ajpheart.1987.252.2.H434

DinhXuan AT, Higenbottan TW, Clelland C, Pepke-Zaba J, Wells FC, Wallwork J (1990) Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J 3(6):633–8

doi: 10.1183/09031936.93.03060633

Liu SF, Barnes PJ (1994) Role of endothelium in the control of pulmonary vascular tone. Endothelium 2(1):11–33. https://doi.org/10.3109/10623329409024631

doi: 10.3109/10623329409024631

Dominguez Rieg JA, Burt JM, Ruth P, Rieg T (2015) P2Y

doi: 10.1111/apha.12446

Jiménez M, Clavé P, Accarino A, Gallego D (2014) Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies. Br J Pharmacol 171:4360–4375

pubmed: 24910216 pmcid: 4209144 doi: 10.1111/bph.12802

Paquola A, Mañé N, Giron MC, Jimenez M (2019) Diadenosine tetraphosphate activates P2Y

pubmed: 31063775 doi: 10.1016/j.ejphar.2019.05.013

Dales MO, Mitchell C, Gurney AM, Drummond RM, Kennedy C (2022) Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists. Purinergic Signal 18(4):515–528

pubmed: 36018534 pmcid: 9832182 doi: 10.1007/s11302-022-09895-x

Bowser JL, Phan LH, Eltzschig HK (2018) The hypoxia-adenosine link during intestinal inflammation. J Immunol 200(3):897–907

pubmed: 29358413 doi: 10.4049/jimmunol.1701414

Eltzschig HK (2013) Extracellular adenosine signaling in molecular medicine. J Mol Med (Berl) 91(2):141–146

pubmed: 23338058 doi: 10.1007/s00109-013-0999-z

Aherne CM, Collins CB, Rapp CR, Olli KE, Perrenoud L, Jedlicka P et al (2018) Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation. JCI Insight 3(20):e121521

pubmed: 30333323 pmcid: 6237472 doi: 10.1172/jci.insight.121521

Wiklund NP, Cederqvist B, Matsuda H, Gustafsson LE (1987) Adenosine can excite pulmonary artery. Acta Physiol Scand 131(3):477–478

pubmed: 3425352 doi: 10.1111/j.1748-1716.1987.tb08266.x

Szentmiklósi AJ, Ujfalusi A, Cseppentő Á, Nosztray K, Kovacs P, Szabó JZ (1995) Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 351(4):417–425. https://doi.org/10.1007/BF00169083

doi: 10.1007/BF00169083 pubmed: 7543187

Roepke JE, Patterson CE, Packer CS, Rhoades RA (1991) Response of perfused lung and isolated pulmonary artery to adenosine. Exp Lung Res 17(1):25–37

pubmed: 2013271 doi: 10.3109/01902149109063279

Haynes Jr J, Obiako B, Thompson WJ, Downey J (1995) Adenosine-induced vasodilation: receptor characterization in pulmonary circulation. Am J Physiol 268(5 Pt 2):H1862–H1868. https://doi.org/10.1152/ajpheart.1995.268.5.H1862

Pearl RG (1994) Adenosine produces pulmonary vasodilation in the perfused rabbit lung via an adenosine A2 receptor. Anesth Analg 79(1):46–51

pubmed: 8010453 doi: 10.1213/00000539-199407000-00010

Steinhorn RH, Morin FC, Van Wylen DG, Gugino SF, Giese EC, Russell JA (1994) Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am J Physiol Circ Physiol 266(5):H2001–H2006

doi: 10.1152/ajpheart.1994.266.5.H2001

El-Kashef H, Elmazar MM, Al-Shabanah OA, Al-Bekairi AM (1999) Effect of adenosine on pulmonary circulation of rabbits. Gen Pharmacol 32(3):307–313

pubmed: 10211584 doi: 10.1016/S0306-3623(98)00184-0

Mentzer RM, Rubio R, Berne R (1975) Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol Content 229(6):1625–1631. https://doi.org/10.1152/ajplegacy.1975.229.6.1625

doi: 10.1152/ajplegacy.1975.229.6.1625

Biaggioni I, King LS, Enayat N, Robertson D, Newman JH (1989) Adenosine produces pulmonary vasoconstriction in sheep. Evidence for thromboxane A2/prostaglandin endoperoxide-receptor activation. Circ Res 65(6):1516–25. https://doi.org/10.1161/01.RES.65.6.1516

doi: 10.1161/01.RES.65.6.1516 pubmed: 2582587

Lippton HL, Hao Q, Hauth T, Hyman A (1992) Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. Am J Physiol 262(3 Pt 2):H926–H929

pubmed: 1348400

Neely CF (1993) Purinergic responses in the feline pulmonary vascular bed. Drug Dev Res 28(3):328–335. https://doi.org/10.1002/ddr.430280326

doi: 10.1002/ddr.430280326

Cheng DY, Dewitt BJ, Suzuki F, Neely CF, Kadowitz PJ (1996). Adenosine A1 and A2 receptors mediate tone-dependent responses in feline pulmonary vascular bed. Am J Physiol - Hear Circ Physiol 270(1 39–1). https://doi.org/10.1152/ajpheart.1996.270.1.H200

McCormack DG, Clarke B, Barnes PJ (1989) Characterization of adenosine receptors in human pulmonary arteries. Am J Physiol Circ Physiol 256(1):H41–H46

doi: 10.1152/ajpheart.1989.256.1.H41

Fullerton DA, Kirson LE, Jones SD, McIntyre RC (1996) Adenosine is a selective pulmonary vasodilator in cardiac surgical patients. Chest 109(1):41–46

pubmed: 8549214 doi: 10.1378/chest.109.1.41

Reid PG, Fraser AG, Watt AH, Henderson AH, Routledge PA (1990) Acute haemodynamic effects of intravenous infusion of adenosine in conscious man. Eur Heart J 11(11):1018–1028

pubmed: 2282921 doi: 10.1093/oxfordjournals.eurheartj.a059629

Katsuragi T, Su C (1980) Purine release from vascular adrenergic nerves by high potassium and a calcium ionophore, A-23187. J Pharmacol Exp Ther 215(3):685–690

pubmed: 6777482

Mohri K, Takeuchi K, Shinozuka K, Bjur RA, Westfalli DP (1993) Simultaneous determination of nerve-induced adenine nucleotides and nucleosides released from rabbit pulmonary artery. Anal Biochem 210(2):262–267

pubmed: 8512061 doi: 10.1006/abio.1993.1194

Husted SE, Nedergaard OA (1985) Dual inhibitory action of ATP on adrenergic neuroeffector transmission in rabbit pulmonary artery. Acta Pharmacol Toxicol (Copenh) 57(3):204–213

pubmed: 2998153 doi: 10.1111/bcpt.1985.57.3.204

Hansen MA, Dutton JL, Balcar VJ, Barden JA, Bennett MR (1999) P2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 75(2–3):147–155

pubmed: 10189116 doi: 10.1016/S0165-1838(98)00189-1

Alencar AKN, Pereira SL, Montagnoli TL, Maia RC, Kümmerle AE, Landgraf SS et al (2013) Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats. Br J Pharmacol 169(5):953–962

pubmed: 23530610 pmcid: 3696320 doi: 10.1111/bph.12193

Helenius MH, Vattulainen S, Orcholski M, Aho J, Komulainen A, Taimen P et al (2015) Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension. Am J Physiol Cell Mol Physiol 308(10):L1046–L1057. https://doi.org/10.1152/ajplung.00340.2014

doi: 10.1152/ajplung.00340.2014

Visovatti SH, Hyman MC, Bouis D, Neubig R, McLaughlin VV, Pinsky DJ (2012) Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension. PLoS ONE 7(7):e40829

pubmed: 22792409 pmcid: 3394716 doi: 10.1371/journal.pone.0040829

Zhang W, Zhang Y, Wang W, Dai Y, Ning C, Luo R et al (2013) Elevated ecto-5′-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res 112(11):1466–1478

pubmed: 23584256 doi: 10.1161/CIRCRESAHA.111.300166

Yin J, You S, Liu H, Chen L, Zhang C, Hu H et al (2017) Role of P2X7R in the development and progression of pulmonary hypertension. Respir Res 18(1):127

pubmed: 28646872 pmcid: 5483271 doi: 10.1186/s12931-017-0603-0

Aherne CM, Saeedi B, Collins CB, Masterson JC, McNamee EN, Perrenoud L et al (2015) Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis. Mucosal Immunol 8(6):1324–1338

pubmed: 25850656 pmcid: 4598274 doi: 10.1038/mi.2015.22

Yuan X, Lee JW, Bowser JL, Neudecker V, Sridhar S, Eltzschig HK (2018) Targeting hypoxia signaling for perioperative organ injury. Anesth Analg 126(1):308–321

pubmed: 28759485 pmcid: 5735013 doi: 10.1213/ANE.0000000000002288

Rafehi M, Müller CE (2018) Tools and drugs for uracil nucleotide-activated P2Y receptors. Pharmacol Ther 190:24–80

pubmed: 29660366 doi: 10.1016/j.pharmthera.2018.04.002

Xu P, Feng X, Luan H, Wang J, Ge R, Li Z et al (2018) Current knowledge on the nucleotide agonists for the P2Y

pubmed: 29254895 doi: 10.1016/j.bmc.2017.11.043

Jacobson KA, Müller CE (2016) Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104:31–49

pubmed: 26686393 doi: 10.1016/j.neuropharm.2015.12.001

Abdelrahman A, Yerande SG, Namasivayam V, Klapschinski TA, Alnouri MW, El-Tayeb A et al (2020) Substituted 4-phenylthiazoles: development of potent and selective A1, A3 and dual A1/A3 adenosine receptor antagonists. Eur J Med Chem 186:111879. https://doi.org/10.1016/j.ejmech.2019.111879

doi: 10.1016/j.ejmech.2019.111879 pubmed: 31780082

Hennigs JK, Lüneburg N, Stage A, Schmitz M, Körbelin J, Harbaum L et al (2019) The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension. Purinergic Signal 15(3):299–311

pubmed: 31396838 pmcid: 6737170 doi: 10.1007/s11302-019-09674-1

Visovatti SH, Hyman MC, Goonewardena SN, Anyanwu AC, Kanthi Y, Robichaud P et al (2016) Purinergic dysregulation in pulmonary hypertension. Am J Physiol - Hear Circ Physiol 311(1):H286–H298. https://doi.org/10.1152/ajpheart.00572.2015

doi: 10.1152/ajpheart.00572.2015

Li LZ, Yue LH, Zhang ZM, Zhao J, Ren LM, Wang HJ et al (2020) Comparison of mRNA expression of P2X receptor subtypes in different arterial tissues of rats. Biochem Genet 58(5):677–690

pubmed: 32385670 doi: 10.1007/s10528-020-09968-9

Aliagas E, Muñoz-Esquerre M, Cuevas E, Careta O, Huertas D, López-Sánchez M et al (2018) Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD. Respir Res 19(1):1–10

doi: 10.1186/s12931-018-0793-0

Careta O, Cuevas E, Muñoz-Esquerre M, López-Sánchez M, Pascual-González Y, Dorca J et al (2019) Imbalance in the expression of genes associated with purinergic signalling in the lung and systemic arteries of COPD patients. Sci Rep 9(1):1–9

doi: 10.1038/s41598-019-39233-y

Purinergic regulation of pulmonary vascular tone.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Marco Alveal (M)

Andrea Méndez (A)

Aline García (A)

Mauricio Henríquez (M)

Classifications MeSH